A pilot study of active immunotherapy with CEA (6D) VRP vaccine (AVX701) in patients with stage III colon cancer.
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
AlphaVax, Inc.
Start Date
October 1, 2013
End Date
September 1, 2021
Administered By
Duke Cancer Institute
Awarded By
AlphaVax, Inc.
Start Date
October 1, 2013
End Date
September 1, 2021